NCT00006280View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

February 28, 2002

Conditions
Cystic Fibrosis
Interventions
DRUG

Tobramycin for Inhalation

Trial Locations (9)

21287

Johns Hopkins Hospital, Baltimore

27599

University of North Carolina - Chapel Hill, Chapel Hill

44106

Rainbow Babies and Children's Hospital, Cleveland

45229

Children's Hospital Medical Center, Cincinnati

77030

Baylor College of Medicine, Houston

80218

The Children's Hospital, Denver

94304

Stanford University/Lucille Packard Children's Health Services at Stanford, Palo Alto

98105

Children's Hospital and Regional Medical Center, Seattle

02115

Children's Hospital, Boston

All Listed Sponsors
collaborator

National Center for Research Resources (NCRR)

NIH

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00006280 - A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis | Biotech Hunter | Biotech Hunter